Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs
The most commonly reported side effects in clinical trials include injection site reactions (redness, swelling, itching), fluid retention, joint pain, and in some cases transient glucose elevation
To test this, we synthesized and characterized the GO@GSH-FA nanocomposite, evaluated its neuroprotective effects in OGD/R cell models, and assessed its therapeutic efficacy in Endothelin-1 (ET-1) induced cortical ischemia models
Liposomal technology ensures phospholipid protection of glutathione from degradation in the digestive tract
The following IV therapies require a provider evaluation and individual order prior to administration due to dosing considerations, therapeutic intent, or medical complexity
boost your energy and reclaim your every day